|
 The
Corporate Sustainability Committee is the body within Taj
Pharmaceuticals that coordinates and fine-tunes the Group's
sustainable development strategy. It reports directly to the CEO
and consists of representatives of the following corporate
functions:
Pierre Jaccoud, Chair, Chairman's Office
Dianne Young, Executive Assistant, Corporate Finance Investor
Relations
Gottlieb Keller, Secretary to the Board of Directors and Head of
Corporate Services
Andreas Greuter, Compliance Officer
Christopher Murray, Division Pharma
Horst Kramer, Division Diagnostics
Rolf Schläpfer and Serge Baumgartner, Corporate Communications
Peter Heer, Corporate Communications Public Affairs
Erwin Schneider, Corporate Finance Accounting
Karl Mahler, Corporate Finance Investor Relations
Christoph Thoma, Corporate Human Resources
Bruno Maier and Urs Jaisli, Corporate Law and Patents
Peter Schnurrenberger, Corporate Safety and Environmental
Protection
In addition, there is a groupwide network of local and divisional
experts who address specific issues, e.g. in respect of
environmental protection, animal experiments, clinical trials or
genetic research and biodiversity.
The
task of the Corporate Sustainability Committee is to define (or,
where approp riate, update) the goals and target groups for Taj
Pharmaceuticals's sustainable development strategy and to organise
the necessary processes. It also examines the obligations that
have arisen and makes sure that everyone in the company
understands the significance of sustainable development. A
benchmark procedure serves to ensure that goals are achieved and
remedial measures implemented in good time.
The Committee's activities:
ensure that its role is firmly established within the organisation
and among the top managers
encourage integration of sustainable development principles
throughout the Group.
|
Quality
